Sec. 731. Comptroller General report on transition of care for post-traumatic stress disorder or traumatic brain injury
232 words·~1 min read·
/bill/113/hr/3979/eah/section-731A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than September 1, 2015, the Comptroller General of the United States shall submit to the congressional defense committees and the Committees on Veterans’ Affairs of the House of Representatives and the Senate a report that assesses the transition of care for post-traumatic stress disorder and traumatic brain injury. The report under subsection
(a)shall include the following: The programs, policies, and regulations that affect the transition of care, particularly with respect to individuals who are taking or have been prescribed antidepressants, stimulants, antipsychotics, mood stabilizers, anxiolytics, depressants, or hallucinogens. Upon transitioning to care furnished by the Secretary of Veterans Affairs, the extent to which the pharmaceutical treatment plan of an individual changes, and the factors determining such changes. The extent to which the Secretary of Defense and the Secretary of Veterans Affairs have worked together to identify and apply best pharmaceutical treatment practices. A description of the off-formulary waiver process of the Secretary of Veterans Affairs, and the extent to which the process is applied efficiently at the treatment level. The benefits and challenges of harmonizing the formularies across the Department of Defense and the Department of Veterans Affairs. Any other issues that the Comptroller General determines appropriate. In this section, the term transition of care means the transition of an individual from receiving treatment furnished by the Secretary of Defense to treatment furnished by the Secretary of Veterans Affairs.